Skin LaxityNCT03966924

The PREFORM Study: Rotational Fractional Resection for Submental Contouring

A study testing Rotational fractional resection (1.5mm Diameter Device) in people with Skin Laxity and Lipodystrophy, run by Recros Medica, Inc. at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record

Search all trials

Trial summary

This study will evaluate the safety and efficacy of rotational fractional resection (RFR) to improve neck contouring. Rotational fractional resection is used to remove loose skin and fat. Read more about this study

Who is it for?: Ages 30 years and olderHealthy volunteers can take part
Conditions the study is for: Skin Laxity, Lipodystrophy
What is being tested?: Rotational fractional resection (1.5mm Diameter Device)
Type of treatment: Medical device
Could I receive a placebo?: No, everyone receives an active treatment
How many people: 2 participants
Where: 1 siteUnited States
Study dates: 20 Mar 2019to 16 Oct 2019
Phase: Interventional
Are there results?: Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

Ages 30 years and older
All sexes
Healthy volunteers accepted
Adult, Older adult

Who may be able to join

Healthy male or female
At least 30 years old
Moderate to severe submental laxity
Up to moderate submental lipodystrophy
Agree to maintain weight (±5%) for the duration of the study

Who cannot join

Previous intervention to treat submental fat or skin laxity
Use of aspirin, ibuprofen, naproxen, or Vitamin E within 14 days of the procedure
Severe acne, cystic acne or acne scars on neck
Trauma of chin or neck area
Skin infection or rash on neck
Psoriasis, hyperpigmentation, eczema, rosacea or vitiligo

Show all 10Show fewer

History of scarring
Body mass index (BMI) >30
Clinically significant bleeding disorder
Anemia, kidney disease, or liver disease

Trial locations and contacts

1 site in 1 country.

United States1 site

Steve Yoelin, MD Medical Associates, Inc.
Newport Beach, California, 92663

Other trials in United States

About this study

Official title: The PREFORM Study: An Exploratory, Single-Center Study to Evaluate the Safety and Efficacy of Rotational Fractional Resection on Submental Contouring and Optimal Peri-Procedure Regimen for Accelerated Recovery

This study will evaluate the safety and efficacy of rotational fractional resection (RFR) to improve neck contouring. Rotational fractional resection is used to remove loose skin and fat.

Read the detailed description

This is a prospective, single-center, single-arm (non-randomized), interventional cohort, non-significant risk (NSR) study designed to investigate the efficacy and safety of Rotational Fractional Resection (skin resection and focal lipectomy) in patients with moderate to severe submental skin laxity. The total duration of study participation for each subject is approximately up to 4 months for each subject from the screening visit to the exit visit. The follow-up period will be approximately 3 months after the procedure. Eligible subjects will complete a total of 11 study visits: screening, procedure, and follow-up visits at 1, 4, 7, 14, 21, 30, 45, 60, and 90 days post-procedure.

Conditions: Skin Laxity, Lipodystrophy
Being tested: Rotational fractional resection (1.5mm Diameter Device)
Keywords: submental, laxity, lipodystrophy
Medical subject headings: Cutis Laxa, Lipodystrophy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Rotational fractional resection (1.5mm Diameter Device)Device
Single treatment of skin resection and with and without focal lipectomy (removal of loose skin and fat)

Study groups in NCT03966924
Study group	Role	What they receive
Rotational fractional resection (1.5mm Diameter Device)	Experimental	Single treatment of skin resection and with and without focal lipectomy (removal of loose skin and fat) Receives: Device: Rotational fractional resection (1.5mm Diameter Device)

What is being measured

The primary outcome is the main question the study is designed to answer.

Number of Participants Who Had at Least One Grade Improvement on the Submental Skin Laxity Scale
Physician investigator rated the submental laxity using the Submental Skin Laxity scale (0 = none, 1 = mild, 2 = moderate, 3 = severe, 4 = very severe)
Measured: 90 days post treatment

Secondary outcomes (2)

Number of Participants Who Were Satisfied With the Appearance of Their Neck and Jawline
Subjects rated their satisfaction of the appearance of their neck and jawline on a Subject Satisfaction Questionnaire. Results reflect subjects who were satisfied ("somewhat satisfied," "satisfied," or "very satisfied").
Measured: 90 days post treatment
Number of Participants With a One Grade Improvement on the Submental Lipodystrophy Scale
Comparison of the submental fat before and after procedure using the Submental Skin Lipodystrophy scale (0 = none, 1 = mild, 2 = moderate, 3 = severe, 4 = very severe)
Measured: 90 days post treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

20 Mar 201916 Oct 2019

First posted29 May 2019
Study start20 Mar 2019
Primary completion16 Oct 2019
Study completion16 Oct 2019

Resources

Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
Other trials for Skin LaxityStudies of the same condition, open and under way.
What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design

Study type: Interventional
Phase: Phase N/A
Primary purpose: Treatment
Allocation: Not applicable
Intervention model: Single group
Masking: None (open label)
Enrolment: 2 participants (actual)

IDs, dates and publications

ClinicalTrials.gov ID: NCT03966924
Sponsor's protocol ID: CLP-0007
Status last verified: Jan 2020
First submitted: 19 Mar 2019
Last updated: 11 May 2021
Results posted: Yes, on ClinicalTrials.gov
Data monitoring committee: No
FDA-regulated drug: No
FDA-regulated device: Yes
Individual data sharing: No

Want to know more?

The sponsor has not listed a contact. The official record may have more details.

Talk to your doctor first and take this page with you. Only the study team can confirm whether you can join.

Questions to ask the study team

What is the study trying to find out?
What would I need to do, and how often would I visit?
Could I receive a placebo instead of the treatment?
What are the possible risks and benefits for me?
Will it cost me anything? Are travel or time paid for?
Can I keep seeing my own doctor during the study?
What happens when the study ends?

See locations

Recruiting
VISION Study: Visualization-Guided SMAS Treatment to Optimize Nonsurgical Lifting
Facial Skin Laxity
Recruiting
Pre-marketing Trial to Assess Safety and Efficacy of 'Volumizing Filler Based on Hyaluronic Acid and Recombinant Collagen'
Wrinkle, Scar
Active, not recruiting
Safety and Efficacy of 2910 nm Fiber Laser Resurfacing and Laser-Coring
Rhytids, Skin Laxity
Not yet recruiting
Safety and Efficacy of a 2,910 nm Fractional Ablative Fiber Laser (UltraClear®) for Improvements of Skin Laxity and Lifting of the Lower Face, Submental, and Neck Treatment Areas
Skin Laxity (Submental and Neck), Skin Lifting and Tightening
Not yet recruiting
Evaluation of SofWave Sofware-Guided Energy Delivery for Lower Face and Neck Rejuvenation
Facial Wrinkles, Jawline Contour

All Skin Laxity trials

Study at a glance

From the registry record, last updated by the sponsor on 11 May 2021. Recruitment status is as the sponsor reported it: confirm with the study team.

Official title: The PREFORM Study: An Exploratory, Single-Center Study to Evaluate the Safety and Efficacy of Rotational Fractional Resection on Submental Contouring and Optimal Peri-Procedure Regimen for Accelerated Recovery
ClinicalTrials.gov ID: NCT03966924
Acronym / sponsor ID: CLP-0007
Conditions: Skin Laxity, Lipodystrophy
Keywords: submental, laxity, lipodystrophy
Study type: Interventional
Recruitment status: Completed
Enrolment: 2 participants (actual)
Lead sponsor: Recros Medica, Inc.Industry (pharma, biotech, devices)
Study start: 20 Mar 2019 (actual)
Primary completion: 16 Oct 2019 (actual)
Study completion: 16 Oct 2019 (actual)
First posted: 29 May 2019 (actual)
Results: Posted 11 Feb 2021

Clinical summary

The research question as the sponsor registered it. This describes what the study plans to test, not what it found.

This study will evaluate the safety and efficacy of rotational fractional resection (RFR) to improve neck contouring. Rotational fractional resection is used to remove loose skin and fat.

Detailed description

Study design

Primary purpose: Treatment
Allocation: Not applicable
Intervention model: Single group
Masking: None (open label)
Number of arms: 1

Arm	Type	Receives
Rotational fractional resection (1.5mm Diameter Device)	Experimental	Device: Rotational fractional resection (1.5mm Diameter Device)Single treatment of skin resection and with and without focal lipectomy (removal of loose skin and fat)

Who may qualify

Ages: 30 years and older
Sex: All
Healthy volunteers: Accepted
Age groups: Adult, Older adult

Key inclusion criteria (5 listed)

Healthy male or female
At least 30 years old
Moderate to severe submental laxity
Up to moderate submental lipodystrophy
Agree to maintain weight (±5%) for the duration of the study

Key exclusion criteria (10 listed)

Previous intervention to treat submental fat or skin laxity
Use of aspirin, ibuprofen, naproxen, or Vitamin E within 14 days of the procedure
Severe acne, cystic acne or acne scars on neck
Trauma of chin or neck area
Skin infection or rash on neck

Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.

Interventions

Intervention	Type	Arms
Rotational fractional resection (1.5mm Diameter Device)Single treatment of skin resection and with and without focal lipectomy (removal of loose skin and fat)	Device	Rotational fractional resection (1.5mm Diameter Device)

Primary outcome

Number of Participants Who Had at Least One Grade Improvement on the Submental Skin Laxity Scale
Time frame: 90 days post treatment
Physician investigator rated the submental laxity using the Submental Skin Laxity scale (0 = none, 1 = mild, 2 = moderate, 3 = severe, 4 = very severe)

2 secondary outcomes

Number of Participants Who Were Satisfied With the Appearance of Their Neck and Jawline
Time frame: 90 days post treatment
Number of Participants With a One Grade Improvement on the Submental Lipodystrophy Scale
Time frame: 90 days post treatment

Results and safety

Results posted to the registry on 11 Feb 2021, as reported by the sponsor. Figures are copied from the record, not re-analysed. Full results on ClinicalTrials.gov.

Participant flow

Group	Started	Completed
Rotational Fractional Resection (1.5mm Diameter Device)	2	2

Primary outcome: Number of Participants Who Had at Least One Grade Improvement on the Submental Skin Laxity Scale

Time frame: 90 days post treatment. Count of participants. Unit: Participants

Measure	Rotational Fractional Resection (1.5mm Diameter Device) n = 2
Value	2

Population analysed: Number of participants with at least a one grade improvement on the Submental Skin Laxity Scale

2 secondary outcomes are reported in the full results.

Adverse events

Time frame: 90 days post treatment. Other adverse events reported at 5% frequency or more

Group	Serious adverse events	Other adverse events	Deaths
Rotational Fractional Resection (1.5mm Diameter Device)	0 of 2 (0%)	1 of 2 (50%)	0 of 2

Limitations and caveats (from the sponsor): This study evaluated 1.5mm diameter skin resections, the first-generation prototype, in the submental area.

Loading the posted results from ClinicalTrials.gov…

Research links

Official record on ClinicalTrials.govLast updated by the sponsor 11 May 2021.
Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
Individual participant dataSharing planned: No

Related trials for Skin Laxity

Recruiting
VISION Study: Visualization-Guided SMAS Treatment to Optimize Nonsurgical Lifting
Facial Skin Laxity
Recruiting
Pre-marketing Trial to Assess Safety and Efficacy of 'Volumizing Filler Based on Hyaluronic Acid and Recombinant Collagen'
Wrinkle, Scar
Active, not recruiting
Safety and Efficacy of 2910 nm Fiber Laser Resurfacing and Laser-Coring
Rhytids, Skin Laxity
Not yet recruiting
Safety and Efficacy of a 2,910 nm Fractional Ablative Fiber Laser (UltraClear®) for Improvements of Skin Laxity and Lifting of the Lower Face, Submental, and Neck Treatment Areas
Skin Laxity (Submental and Neck), Skin Lifting and Tightening
Not yet recruiting
Evaluation of SofWave Sofware-Guided Energy Delivery for Lower Face and Neck Rejuvenation
Facial Wrinkles, Jawline Contour

Referral and contact

AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.

Robin McIntosh study director

Recros Medica

1 site in 1 country: see every site and its status.

Questions about this trial

What is this clinical trial studying?

A study testing Rotational fractional resection (1.5mm Diameter Device) in people with Skin Laxity and Lipodystrophy, run by Recros Medica, Inc. at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 May 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 11 Feb 2021). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of Participants Who Had at Least One Grade Improvement on the Submental Skin Laxity Scale (time frame: 90 days post treatment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03966924.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 May 2021; AzTrials last refreshed its copy on 2 Nov 2026.